| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 07/17/2008 | WO2007092961A3 Antibacterial agents |
| 07/17/2008 | US20080171776 6-oxazol-4-ylmetholmethoxy-alko-alkoxymethyl substituted benzoic acid derivatives forming peroxisome proliferator - activated receptor (ppar) ligands, process for their preparation and methods of use thereof |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | US20080171681 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners |
| 07/16/2008 | EP1943217A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 07/16/2008 | CN101223150A Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate |
| 07/16/2008 | CN101222950A Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids |
| 07/16/2008 | CN101220003A Propargylterminated compounds with benzoxazole ring and method for producing the same |
| 07/16/2008 | CN101220002A Oxazolidinone compound as antimicrobial |
| 07/16/2008 | CN101220001A Synthesis of linezolid |
| 07/16/2008 | CN100402510C Oxazole derivatives and their use as insulin sensitizers |
| 07/15/2008 | US7399777 Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals |
| 07/15/2008 | US7399775 β-amyloid protein production/secretion inhibitor |
| 07/15/2008 | US7399765 Substituted diazabicycloalkane derivatives |
| 07/15/2008 | US7399470 Monoclonal antibodies produced by hybridomas via haptens |
| 07/15/2008 | US7399319 Applying to the keratin fibers styryl and imine dye compounds comprising a heterocycle that can undergo opening and/or dyes corresponding to these compounds whose heterocycles are open; chromatic and fast with respect to external factors such as shampooing, does not stain, and/or allows dyeing and bleach |
| 07/10/2008 | WO2008082567A1 Process for synthesizing a cetp inhibitor |
| 07/10/2008 | WO2008081537A1 Aromatic amino acid derivative with lat1 inhibitory activity, lat1 inhibitor containing the same and method for producing the same |
| 07/10/2008 | WO2008048991A3 Organic compounds |
| 07/10/2008 | WO2008036652A3 Amidines as modulators of indoleamine 2,3-dioxygenase |
| 07/10/2008 | US20080167369 Semisynthesis Process for the Preparation of 10-Deacytyl-N-Debenzoyl-Paclitaxel |
| 07/10/2008 | US20080167355 Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors |
| 07/10/2008 | US20080167354 Treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization and insulin resistance; 2-(hetero)aryloxazol-4-ylalkylcycloalkyl group, (2R/2S)-3-[(1R,3S)-3-(5-methyl-2-m-tolyloxazol-4-ylmethoxymethyl)-cyclohexyloxy ]-2-(4-trifluoromethylbenzyloxy)propionic acid |
| 07/10/2008 | US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders |
| 07/09/2008 | EP1940776A2 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | CN101218213A Processes for production of phenolic 4-biphenylylazetidin-2-ones |
| 07/09/2008 | CN101217954A Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 07/09/2008 | CN101215322A Artificial antigen and antibody of furazolidone metabolite 3-amino-2-oxazolidone and preparation method thereof |
| 07/09/2008 | CN100400533C Valerolactone compounds and perfume composition |
| 07/09/2008 | CN100400504C Amide derivatives as inhibitors of the enzymatic activity of renin |
| 07/08/2008 | US7396848 oxazole derivatives to treat diabetic neuropathy and/or other kinds of peripheral neuropathy; 4-(4-chlorophenyl)-5-[3-(2-methoxyphenoxy)propyl]-2-(2-methyl-1-imidazolyl)oxazole |
| 07/08/2008 | US7396847 Oxazolidinone and/or isoxazoline as antibacterial agents |
| 07/08/2008 | US7396838 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/03/2008 | WO2008078674A1 Glucokinase-activating substance |
| 07/03/2008 | WO2008077188A1 Bicyclic pyrimidinones and uses thereof |
| 07/03/2008 | US20080161374 Pyrazole compounds and uses related thereto |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080161308 e.g. 4-[6-(2-cyclohexylethoxy)-3-oxoindan-5-yloxy]butanoic acid; peroxisome proliferator-activated receptor (PPAR) gamma agonist; antiinflammatory, antidiabetic agent; dyslipidaemia, atherosclerosis, insulin resistance |
| 07/03/2008 | CA2673466A1 Substituted tetracycline compounds |
| 07/03/2008 | CA2673183A1 Bicyclic pyrimidinones and uses thereof |
| 07/03/2008 | CA2672727A1 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| 07/03/2008 | CA2672088A1 Glucokinase activator |
| 07/02/2008 | EP1939188A1 Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/02/2008 | EP1937655A1 Hiv-1 protease inhibitors, and methods of making and using them |
| 07/02/2008 | EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | CN101213199A Compounds for preparing immunological adjuvant |
| 07/02/2008 | CN101213170A Process for production of 4-biphenylylazetidin-2-ones |
| 07/02/2008 | CN101212966A Process for synthesizing a CETP inhibitor |
| 07/02/2008 | CN101209998A Method for synthesizing 5-amide-6-hydroxy-2-(4-carboxylphenyl)benzoxazole |
| 07/02/2008 | CN100398537C Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | CN100398536C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 07/02/2008 | CN100398526C 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 07/02/2008 | CN100398105C 1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals |
| 07/01/2008 | US7393873 Arylsulfonamide derivatives |
| 06/26/2008 | WO2008076754A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 06/26/2008 | WO2008075565A1 Display element and method for driving the same |
| 06/26/2008 | WO2008021851A3 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 06/26/2008 | WO2006104755A3 Pretreatment compositions |
| 06/26/2008 | US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 06/26/2008 | US20080153836 1H-Quinazoline-2,4-Diones |
| 06/26/2008 | US20080153812 Novel compounds |
| 06/26/2008 | CA2672271A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 06/25/2008 | EP1934192A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 06/25/2008 | EP1934190A2 An improved process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol |
| 06/25/2008 | EP1934189A2 A process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol |
| 06/25/2008 | EP1933834A1 Benzoxazoles useful in the treatment of inflammation |
| 06/25/2008 | CN101208315A Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors |
| 06/25/2008 | CN101205202A Substituted benzene urea compounds as well as preparation and uses thereof |
| 06/25/2008 | CN100396672C N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides |
| 06/24/2008 | US7390875 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 06/24/2008 | US7390833 osteoarthritis; compounds inhibit Aggrecanase Activity of a disintegrin and metalloprotease with thrombosondin type I motifs; biaryl sulfonamid derivatives; N-({4'-[2-4-methylisoquinolin-3-yl)ethyl]-1,1 '-biphenyl-4-yl}sulfonyl)-D-valine |
| 06/24/2008 | US7390826 Inhibitors of animal cell motility and growth |
| 06/24/2008 | US7390825 Process for the preparation of oxazolidinones and method of use thereof |
| 06/19/2008 | WO2008072849A1 Method of preparing docetaxel and intermediates used therein |
| 06/19/2008 | WO2008071944A1 Benzoxazoles useful in the treatment of inflammation |
| 06/19/2008 | WO2007062316A3 Trans-3,5-disubstitutedpyrrolidine: organocatalyst for anti-mannich reactions |
| 06/19/2008 | US20080146797 Process for synthesizing heterocyclic compounds |
| 06/19/2008 | US20080146631 Peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis |
| 06/19/2008 | US20080146630 Estrogen receptor modulators; neurodegenerative disorders; cognitive enhancement |
| 06/19/2008 | US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/19/2008 | US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof |
| 06/19/2008 | US20080146458 Process for the preparation of oxazolidinones and method of use thereof |
| 06/18/2008 | EP1932837A1 Bicyclo heterocyclic compound having antifungal action |
| 06/18/2008 | EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 06/18/2008 | EP0885210B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use |
| 06/18/2008 | CN100395239C Method for preparing carbamido alanine protected by Na-Boc |
| 06/17/2008 | US7388031 Reacting an epoxy compound with a aminocylcohexane-phenyl derivative; useful as anti-obesity, anti-diabetic, cicatrizing and tocolytic medicinal products |
| 06/17/2008 | US7388023 Amino acids with affinity for the α2δ-protein |
| 06/12/2008 | WO2008070619A1 Deuterated oxazolidinones and their use as antibiotics |
| 06/12/2008 | WO2008070111A2 Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| 06/12/2008 | WO2008069813A1 Photosensitive polyimides and methods of making the same |
| 06/12/2008 | WO2008069812A1 Photosensitive polybenzoxazines and methods of making the same |
| 06/12/2008 | WO2008069619A1 Novel oxazolidinone derivatives, process for preparing thereof and pharmaceutical composition containing the same |
| 06/12/2008 | WO2008069611A1 N-phenylamide derivative, process for the preparation thereof, and composition for preventing or treating ischemic diseases comprising same |
| 06/12/2008 | WO2008069313A1 Method for producing pyrrolidine compound |
| 06/12/2008 | WO2007089548A3 Compounds and methods for modulating protein trafficking |